{"id":"W3048875481","doi":"10.1097/spc.0000000000000519","title":"Second-line tyrosine kinase inhibitor-therapy after immunotherapy-failure","year":2020,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pazopanib; Axitinib; Cabozantinib; Immunotherapy; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Sunitinib; Renal cell carcinoma; Pharmacology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005748048,0.0006788827,0.001942991,0.001793019,0.0001878544,0.000943146,0.0007898516,0.0007534289,0.004514963],"category_scores_gemma":[0.001451571,0.0001528741,0.001001103,0.002004471,0.0002838685,0.0008435372,0.0004007327,0.0007661373,0.0008555936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005220558,"about_ca_system_score_gemma":0.001411391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009144978,"about_ca_topic_score_gemma":0.002152345,"domain_scores_codex":[0.999697,0.00007269919,0.00007675547,0.00005552007,0.00007838049,0.00001966857],"domain_scores_gemma":[0.999297,0.0004289544,0.0001652966,0.00001354993,0.00007508724,0.00002011579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001344136,0.00004797403,0.0003247394,0.1958383,0.0006951665,0.0002687431,0.00006655087,0.0002992872,0.0006054261,0.001313705,0.02030169,0.7801042],"study_design_scores_gemma":[0.0001340861,0.0002883274,0.003513003,0.128252,0.003478185,0.004918948,0.0001684701,0.0002176891,0.0007946775,0.001428556,0.8567676,0.00003851132],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001051465,0.9993605,0.00003306591,0.00006281542,0.00008115364,0.000006772513,0.00002279759,0.000002651439,0.0003250287],"genre_scores_gemma":[0.0009540812,0.9986236,0.00006717618,0.000116775,0.00006810312,0.000007822935,0.00004012272,0.000001005956,0.0001212823],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004514963,"threshold_uncertainty_score":0.01510406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1114292077804019,"score_gpt":0.3930083387151905,"score_spread":0.2815791309347887,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}